GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Total Stockholders Equity

Alpa Laboratories (NSE:ALPA) Total Stockholders Equity : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Total Stockholders Equity?

Alpa Laboratories's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alpa Laboratories's Book Value per Share for the quarter that ended in Dec. 2023 was ₹N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alpa Laboratories's Debt-to-Equity for the quarter that ended in Dec. 2023 was .

Alpa Laboratories Total Stockholders Equity Historical Data

The historical data trend for Alpa Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Total Stockholders Equity Chart

Alpa Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 984.94 1,003.73 1,076.41 1,217.31 1,345.78

Alpa Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,345.78 - 1,433.19 -

Alpa Laboratories  (NSE:ALPA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alpa Laboratories's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0-0)/21.0406
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alpa Laboratories's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alpa Laboratories's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpa Laboratories (NSE:ALPA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (NSE:ALPA) » Definitions » Total Stockholders Equity
Comparable Companies
BOM:524518 BOM:531173 BOM:537536 BOM:532637 NSE:VAISHALI BOM:524824 BOM:532384 BOM:530313 NSE:SOTAC BOM:540702 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
532878:India
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Website
https://www.alpalabs.in
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.